A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
This deletion removes a single ribosomal protein-coding gene (though other genes are also removed).
Heterozygous Df(2L)BSC217 mutant females exhibit a dilated cardiomyopathy phenotype, including an increased end-systolic dimension (EDD) and a decreased fractional shortening (FS) compared to controls. Bristles appear short and thin compared to wild type (Minute phenotype).
Flies heterozygous for the deletion show a Minute bristle phenotype.